|
Rezolute, Inc. (RZLT) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Rezolute, Inc. (RZLT) Bundle
Entdecken Sie den finanziellen Ausblick von Rezolute, Inc. (RZLT) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Projektionen für Wachstum, Margen und Kosten ein, um den inneren Wert von Rezolute, Inc. (RZLT) zu bestimmen und Ihre Anlagestrategie zu verbessern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -20.3 | -22.9 | -41.8 | -51.4 | -68.4 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .0 | .3 | .3 | .4 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -20.3 | -23.2 | -42.1 | -51.8 | -68.5 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 10.0 | 41.0 | 150.4 | 101.9 | 126.9 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .9 | 1.0 | 1.1 | 3.3 | 4.9 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -20.3 | -23.6 | -39.8 | -51.8 | -68.5 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -19.4 | -23.2 | -39.4 | -49.4 | -66.8 | -4.9 | .0 | .0 | .0 | .0 |
| WACC, % | 9.19 | 9.19 | 9.19 | 9.19 | 9.19 | 9.19 | 9.19 | 9.19 | 9.19 | 9.19 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | -68 | |||||||||
| Equity Value | 64 | |||||||||
| Diluted Shares Outstanding, MM | 51 | |||||||||
| Equity Value Per Share | 1.24 |
What You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled real RZLT financial data.
- Accurate Data: Historical figures and forward-looking projections (highlighted in the yellow cells).
- Assumption Flexibility: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe the effects of your inputs on Rezolute’s valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for simplicity and ease of navigation, complete with step-by-step guidance.
Key Features
- Comprehensive Financial Data: Gain access to precise historical information and forward-looking estimates for Rezolute, Inc. (RZLT).
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Automated Calculations: Instant updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly graphs and summaries to help you interpret your valuation findings.
- Suitable for All Skill Levels: An intuitive layout designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Rezolute, Inc. (RZLT) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Rezolute, Inc. (RZLT)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Rezolute, Inc. (RZLT)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Rezolute, Inc.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Rezolute’s intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable starting points for analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and business consultants focusing on Rezolute, Inc.
Who Should Use This Product?
- Investors: Evaluate Rezolute, Inc.’s (RZLT) market performance before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methods and assess future forecasts for Rezolute, Inc. (RZLT).
- Startup Founders: Gain insights into how companies like Rezolute, Inc. (RZLT) are valued in the market.
- Consultants: Provide clients with comprehensive valuation analyses and reports on Rezolute, Inc. (RZLT).
- Students and Educators: Utilize real-time data from Rezolute, Inc. (RZLT) to enhance learning in valuation practices.
What the Template Contains
- Pre-Filled DCF Model: Rezolute, Inc.'s (RZLT) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Rezolute, Inc.'s (RZLT) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.